Genotype-Directed Phase II Study Of Higher Dose Of Irinotecan In First-Line Metastatic Colorectal Cancer Patients Treated With Folfiri Plus Bevacizumab
Phase of Trial: Phase II
Latest Information Update: 24 Feb 2019
Price : $35 *
At a glance
- Drugs Irinotecan (Primary)
- Indications Colon cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 02 Jun 2015 Study design presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 29 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrial.gov record.